The Saudi Arabia Blood Collection Market was valued at USD 85.5 million in 2024 and is estimated to grow at a CAGR of 5% to reach USD 138.7 million by 2034.
Market expansion is driven by the high prevalence of genetic blood disorders, including thalassemia and sickle cell anemia, alongside the rising incidence of road traffic accidents and trauma cases. The ongoing development of healthcare infrastructure, increasing surgical procedures, and expansion of emergency care facilities are further fueling demand. Blood collection devices are essential medical tools designed to safely and efficiently draw blood for diagnostics, transfusions, and research purposes. Hospitals, laboratories, and blood banks rely heavily on these devices to support clinical workflows. The surge in surgical and emergency care procedures requires a wide array of blood collection tools for both pre-operative testing and intra-operative transfusions. Increasing awareness of blood disorders, combined with improved healthcare delivery systems, is boosting the adoption of advanced blood collection solutions across Saudi Arabia.
The consumables segment held 76.8% share in 2024, driven by their precision and ability to support multiple types of blood tests. This category includes single-use items such as blood collection tubes, needles, lancets, blood bags, and micro-container tubes, which are indispensable for routine sampling, diagnostic testing, and transfusions. As Saudi Arabia expands healthcare facilities and surgical services, demand for these consumables is growing sharply due to their role in ensuring safe, sterile, and efficient blood handling.
The diagnostics segment held a 50.2% share in 2024, owing to the increasing number of procedures requiring blood samples for disease screening and chronic condition monitoring, such as diabetes, cardiovascular disorders, and cancer. Diagnostic applications rely on blood collection devices for clinical testing, screening, and health monitoring across hospitals, laboratories, and other points of care. This includes the use of vacuum tubes and capillary collection systems, enabling accurate analysis for a wide range of conditions, from genetic disorders to infectious diseases.
The hospitals and clinics segment held a 37% share in 2024, as they manage a high volume of patients requiring routine blood tests, emergency diagnostics, and pre- and post-operative assessments. Public, private, and specialty hospitals are the primary consumers of blood collection products in Saudi Arabia, driving consistent market demand.
Key companies operating in the Saudi Arabia Blood Collection Market include Abbott Laboratories, Becton, Dickinson, and Company, Cardinal Health, F. Hoffmann-La Roche, FL MEDICAL, Fresenius, Greiner, Haemonetics Corporation, McKesson Corporation, Nipro Corporation, QIAGEN, Sarstedt, Siemens Healthineers, Terumo Corporation, and Thermo Fisher Scientific. Companies in the Saudi Arabia Blood Collection Market are leveraging multiple strategies to strengthen their market position. They are investing in R&D to develop safer, more precise, and user-friendly devices, while expanding product portfolios to meet rising demand across diagnostics, transfusions, and research. Strategic collaborations with hospitals, clinics, and diagnostic centers allow wider product distribution and improved adoption rates. Businesses are also focusing on geographic expansion, particularly in emerging urban regions, alongside initiatives to enhance supply chain efficiency, reduce costs, and ensure timely delivery.
This product will be delivered within 2-4 business days.
Market expansion is driven by the high prevalence of genetic blood disorders, including thalassemia and sickle cell anemia, alongside the rising incidence of road traffic accidents and trauma cases. The ongoing development of healthcare infrastructure, increasing surgical procedures, and expansion of emergency care facilities are further fueling demand. Blood collection devices are essential medical tools designed to safely and efficiently draw blood for diagnostics, transfusions, and research purposes. Hospitals, laboratories, and blood banks rely heavily on these devices to support clinical workflows. The surge in surgical and emergency care procedures requires a wide array of blood collection tools for both pre-operative testing and intra-operative transfusions. Increasing awareness of blood disorders, combined with improved healthcare delivery systems, is boosting the adoption of advanced blood collection solutions across Saudi Arabia.
The consumables segment held 76.8% share in 2024, driven by their precision and ability to support multiple types of blood tests. This category includes single-use items such as blood collection tubes, needles, lancets, blood bags, and micro-container tubes, which are indispensable for routine sampling, diagnostic testing, and transfusions. As Saudi Arabia expands healthcare facilities and surgical services, demand for these consumables is growing sharply due to their role in ensuring safe, sterile, and efficient blood handling.
The diagnostics segment held a 50.2% share in 2024, owing to the increasing number of procedures requiring blood samples for disease screening and chronic condition monitoring, such as diabetes, cardiovascular disorders, and cancer. Diagnostic applications rely on blood collection devices for clinical testing, screening, and health monitoring across hospitals, laboratories, and other points of care. This includes the use of vacuum tubes and capillary collection systems, enabling accurate analysis for a wide range of conditions, from genetic disorders to infectious diseases.
The hospitals and clinics segment held a 37% share in 2024, as they manage a high volume of patients requiring routine blood tests, emergency diagnostics, and pre- and post-operative assessments. Public, private, and specialty hospitals are the primary consumers of blood collection products in Saudi Arabia, driving consistent market demand.
Key companies operating in the Saudi Arabia Blood Collection Market include Abbott Laboratories, Becton, Dickinson, and Company, Cardinal Health, F. Hoffmann-La Roche, FL MEDICAL, Fresenius, Greiner, Haemonetics Corporation, McKesson Corporation, Nipro Corporation, QIAGEN, Sarstedt, Siemens Healthineers, Terumo Corporation, and Thermo Fisher Scientific. Companies in the Saudi Arabia Blood Collection Market are leveraging multiple strategies to strengthen their market position. They are investing in R&D to develop safer, more precise, and user-friendly devices, while expanding product portfolios to meet rising demand across diagnostics, transfusions, and research. Strategic collaborations with hospitals, clinics, and diagnostic centers allow wider product distribution and improved adoption rates. Businesses are also focusing on geographic expansion, particularly in emerging urban regions, alongside initiatives to enhance supply chain efficiency, reduce costs, and ensure timely delivery.
Comprehensive Market Analysis and Forecast
- Industry trends, key growth drivers, challenges, future opportunities, and regulatory landscape
- Competitive landscape with Porter’s Five Forces and PESTEL analysis
- Market size, segmentation, and regional forecasts
- In-depth company profiles, business strategies, financial insights, and SWOT analysis
This product will be delivered within 2-4 business days.
Table of Contents
Chapter 1 Methodology and Scope
Chapter 2 Executive Summary
Chapter 3 Industry Insights
Chapter 4 Competitive Landscape, 2024
Chapter 5 Market Estimates and Forecast, by Product Type, 2021-2034 ($ Mn)
Chapter 6 Market Estimates and Forecast, by Method, 2021-2034 ($ Mn)
Chapter 7 Market Estimates and Forecast, by Application, 2021-2034 ($ Mn)
Chapter 8 Market Estimates and Forecast, by End Use, 2021-2034 ($ Mn)
Chapter 9 Company Profiles
Companies Mentioned
The companies profiled in this Saudi Arabia Blood Collection market report include:- Abbott Laboratories
- Becton, Dickinson and Company
- Cardinal Health
- F. Hoffmann-La Roche
- FL MEDICAL
- Fresenius
- Greiner
- Haemonetics Corporation
- McKesson Corporation
- Nipro Corporation
- QIAGEN
- Sarstedt
- Siemens Healthineers
- Terumo Corporation
- Thermo Fisher Scientific
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 60 |
| Published | December 2025 |
| Forecast Period | 2024 - 2034 |
| Estimated Market Value ( USD | $ 85.5 Million |
| Forecasted Market Value ( USD | $ 138.7 Million |
| Compound Annual Growth Rate | 5.0% |
| Regions Covered | Saudi Arabia |
| No. of Companies Mentioned | 16 |
